PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver.
Saito-Yabe M, Kasuya Y, Yoshigae Y, Yamamura N, Suzuki Y, Fukuda N, Honma M, Yano K, Mochizuki S, Okada F, Okada A, Nagayama Y, Tsuda E, Fischer T, Höpner U, Zaja S, Mueller J, Okada J, Kurihara A, Ikeda T, Okazaki O.
Saito-Yabe M, et al. Among authors: honma m.
J Pharm Pharmacol. 2010 Aug;62(8):985-94. doi: 10.1111/j.2042-7158.2010.01120.x.
J Pharm Pharmacol. 2010.
PMID: 20663032